5 results
Aimovig (Erenumab)
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist 
Indication: Preventive Treatment of Migraines:
Dosing: 70 mg SQ monthly,
Aimovig (Erenumab ... primary side effects being ... injection site ... Erenumab #Migraine #Neurology ... #Pharmacology #
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
Etiology: • Pathophysiology ... sequences improve sensitivity ... Diagnosis: • Infection ... Syndrome #diagnosis #management ... #neurology
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
monophasic Pathophysiology ... Direct microbial infection ... Hyperreflexia develops later ... Myelitis #diagnosis #management ... #neurology #differential
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Pathophysiology ... response preceding infection ... Can begin in arms ... Syndrome #diagnosis #management ... #treatment #neurology
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
antigen assay has a sensitivity ... Aspergillosis Pathophysiology ... shock • Mortality rate ... Fungal #Diagnosis #Management ... #Infections